Allgayer Hubert, Dietrich Christoph F, Rohde Wolfgang, Koch Günther F, Tuschhoff Thomas
Department Oncology, Rehaklinik Ob der Tauber der LVA Baden-Württemberg, Bad Mergentheim, Academic Teaching Hospital, University of Heidelberg, Bad Mergentheim, Germany.
Scand J Gastroenterol. 2005 Oct;40(10):1168-75. doi: 10.1080/00365520510023477.
The influence of irradiation on the clinical severity of incontinence, sphincter function, morphologic features and short/long-term treatment effects of sphincter training therapy is still insufficiently understood in irradiated patients with fecal incontinence after surgery for colorectal cancer. These parameters were compared in irradiated and non-irradiated patients and followed prospectively with regard to short- and long-term training effects.
Forty-one patients having been irradiated after surgery (50.0+/-5.0 Gy) and 54 non-irradiated patients with fecal incontinence participated in this prospective, non-randomized trial. Baseline evaluation included a semiquantitative severity assessment score of fecal incontinence (modified Cleveland Incontinence Score (MCIS)), rectal manometry and endoscopy. After 3 weeks (short term) of intensive in-hospital pelvic floor exercise combined with biofeedback training, a second evaluation was made. In addition, anal endosonography (EUS) was performed in cases of treatment failure. After one year (long term) a third evaluation was made clinically (MCIS score).
Irradiated patients presented with a significantly higher degree of fecal incontinence (lower MCIS) compared to non-irradiated patients: 7.4+/-2.2 versus 8.7+/-2.7 points (p<0.001). Rectosigmoidal inflammation was more frequent in irradiated than non-irradiated patients (26.9% versus 9.3%) (p<0.03). Sphincter pressure, sensation/pain threshold and the rectoanal inhibitory reflex were similar in both groups. A significant short-term training effect was observed in both groups following sphincter training therapy in terms of an increase in MCIS from 7.4+/-2.2 to 9.4+/-2.7 points in the irradiated group and from 8.7+/-2.7 to 11.4+/-2.5 points in the non-irradiated group (p<0.0001). After one year the scores were 8.2+/-3.8 and 10.7+/-4.4 points, respectively (p<0.0001). There was a significant correlation (p<0.001) between baseline MCIS and the short- and long-term MCIS. In patients with short-term treatment failure (16.6%) anal EUS revealed structural defects of the external sphincter in four patients. There was no association of sphincter diameter with sphincter pressure, sensation/pain threshold and short/long-term MCIS.
The main result of this study is that irradiated patients show short- and long-term training effects comparable with those of non-irradiated patients despite the higher degree of incontinence at baseline. The correlation between the initial MCIS and short- and long-term treatment effects may be regarded as an important clinical predictor for treatment outcome. Functional and morphologic features are less suitable for this purpose.
对于接受过放疗的结直肠癌术后大便失禁患者,放疗对失禁临床严重程度、括约肌功能、形态学特征以及括约肌训练疗法的短期/长期治疗效果的影响仍未得到充分了解。对接受放疗和未接受放疗的患者的这些参数进行比较,并对短期和长期训练效果进行前瞻性随访。
41例术后接受放疗(50.0±5.0 Gy)的患者和54例未接受放疗的大便失禁患者参与了这项前瞻性、非随机试验。基线评估包括大便失禁的半定量严重程度评估评分(改良克利夫兰失禁评分(MCIS))、直肠测压和内镜检查。在进行3周(短期)的强化住院盆底肌锻炼联合生物反馈训练后,进行第二次评估。此外,对于治疗失败的病例进行肛门腔内超声检查(EUS)。1年后(长期)进行第三次临床评估(MCIS评分)。
与未接受放疗的患者相比,接受放疗的患者大便失禁程度明显更高(MCIS更低):分别为7.4±2.2分和8.7±2.7分(p<0.001)。接受放疗的患者直肠乙状结肠炎症比未接受放疗的患者更常见(26.9%对9.3%)(p<0.03)。两组的括约肌压力、感觉/疼痛阈值和直肠肛门抑制反射相似。在两组中,括约肌训练疗法后均观察到显著的短期训练效果,接受放疗组的MCIS从7.4±2.2分增加到9.4±2.7分,未接受放疗组从8.7±2.7分增加到11.4±2.5分(p<0.0001)。1年后,评分分别为8.2±3.8分和10.7±4.4分(p<0.0001)。基线MCIS与短期和长期MCIS之间存在显著相关性(p<0.001)。在短期治疗失败的患者(16.6%)中,肛门EUS显示4例患者的外括约肌存在结构缺陷。括约肌直径与括约肌压力、感觉/疼痛阈值以及短期/长期MCIS之间无关联。
本研究的主要结果是,尽管接受放疗的患者基线时失禁程度更高,但他们显示出与未接受放疗的患者相当的短期和长期训练效果。初始MCIS与短期和长期治疗效果之间的相关性可被视为治疗结果的重要临床预测指标。功能和形态学特征不太适合用于此目的。